Dems, Multiple Sclerosis Activists Target High Drug Prices

Legislators and the National Multiple Sclerosis Society have launched separate efforts to investigate rising drug costs for multiple sclerosis.

According to the NMSS, MS therapies saw spike to $78,000 from $16,000 between 2004 and 2016.

Click here to read more on Gears of Biz.

You might also be interested in:

Laws Targeting Cancer Drug Costs Falling Short November 13, 2017
Urgent Care Claims Post Huge Spike, According to New Data March 23, 2018
ICER’s Updated Assessment of New Targeted Therapies for… June 13, 2018
LJAF Effort Targets Rising Health System Prices September 27, 2018
Trump Unveils Plan to Combat High Drug Prices May 11, 2018
ICER Releases Report on Antiandrogen Therapies for… August 25, 2018
Group Says Medicare Part D Can Pull Back Rising Costs by… August 20, 2018